On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.
Fiche publication
Date publication
juillet 2021
Journal
Clinical lymphoma, myeloma & leukemia
Auteurs
Membres identifiés du Cancéropôle Est :
Pr RUBIO Marie Thérèse , Dr DAGUINDAU Etienne, Dr D'AVENI-PINEY Maud
Tous les auteurs :
Campidelli A, Robin M, Remen T, Luc A, Labussière-Wallet H, Dulery R, Srour M, Ceballos P, Forcade E, Nguyen-Quoc S, Furst S, Turlure P, Bay JO, Simand C, Marçais A, Daguindau E, Rubio MT, D'Aveni M
Lien Pubmed
Résumé
Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) remains the best curative option for high-risk myelodysplastic syndrome . We retrospectively compared patient outcomes after allo-HSCT according to the intensity of the conditioning regimen.
Mots clés
Allogeneic stem cell transplantation, Conditioning regimen, Covariate adjustment using the propensity, Myelodysplastic syndrome, Overall survival
Référence
Clin Lymphoma Myeloma Leuk. 2021 Jul 31;: